Young Living Says Consumers Not Swayed By Claim But Expect Its Essential Oils Are ‘Therapeutic’
Direct Seller Appeals Industry Self-Regulation Group’s Finding To Pull Claim, Change Labels
In NAD review on a challenge by S.C. Johnson, which markets Caldrea brand essentials oils, Young Living said because consumers are equally as likely to believe the products are therapeutic grade regardless of which image they saw in a survey demonstrates the claim doesn’t impact consumers’ perception of its products.
You may also be interested in...
FDA and FTC submit another three warnings to consumer health marketers making bogus claims to prevent or treat COVID-19. FTC also announces California firm agreed to court order to stop claiming a supplement consisting mainly of vitamin C and herbal extracts is an effective treatment.
A BBB National Programs, Inc. investigative unit tells FTC that Dose of Nature failed to respond to its request to support its CBD oil claims; Utah direct sellers Young Living and doTerra agree to pull or modify drug claims for their essential oil products; HempWorx relabels topical as cosmetic.
FTC joins FDA in one of the three warning letters to firms claiming their products can either prevent or treat Ebola. One firm’s website offers a video titled, “Urgent Message to Ebola-Stricken Nations' Heads of State,” and another claims “primary uses for oregano include athlete’s foot, candida, canker sores, Ebola virus.”